Mice infection with HIV-1: a new mouse model for HIV-1 in vivo research.

G. Filice, P. M. Cereda, P. Orsolini, L. Soldini, R. Gulminetti, E. Romero

Research output: Contribution to journalArticlepeer-review


In mice experimentally infected with 1 x 10(5) UI/mouse of HTLV-IIIB IgM antibodies were detected 10-12 days after the infection, reaching peak values two weeks later; the IgM seratiter progressively decreased thereafter and was negative at ten-eleven weeks. HIV p24 antigen was detected ten-fifteen days after infection and reached peak values five-six weeks later. Antigenemia subsequently decreased and showed an oscillating course with a progressive decrease which persisted throughout the observation period. Two weeks after infection we detected IgG antibodies to the major core protein p24; reactivity to gp41 was observed as early as reactivity to p24 and persisted throughout observation period. The IgG antibodies to all HIV epitopes peaked two-three weeks after infection; the time course showed a decrease after ten weeks, progressively decreasing thereafter. After sixty-five weeks of infection the IgG seratiter value was lower but remained positive. Viruses indistinguishable from HIV were isolated from the peripheral blood mononuclear cells of infected mice 30, 60, 180 days after infection. These seroimmunological and virological data confirm that the immunocompetent mouse may serve as a low-cost reproducible model for HIV-1 in vivo research.

Original languageEnglish
Pages (from-to)167-175
Number of pages9
Issue number2
Publication statusPublished - Apr 1992

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology


Dive into the research topics of 'Mice infection with HIV-1: a new mouse model for HIV-1 in vivo research.'. Together they form a unique fingerprint.

Cite this